BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 6, 2011
View Archived Issues
Promising findings made available from dal-VESSEL trial
Read More
Data disclosed from ARISTOTLE trial of apixaban vs. warfarin in atrial fibrillation
Read More
Daiichi Sankyo identifies new pyrrolobenzoxazepine derivatives
Read More
Eisai divulges additional phase III data on proprietary AMPA-type glutamate receptor antagonist
Read More
Lu-AA-21004 prevents relapse of major depression in long-term trial
Read More
Methylene blue beneficial as adjunctive therapy for bipolar disorder
Read More
New progesterone receptor antagonists claimed
Read More
New peroxisome proliferator-activated receptor-gamma agonists presented
Read More
Novel sanglifehrin analogues reported
Read More
Shionogi & Co. claims new neuropeptide Y5 receptor antagonists
Read More
Astellas Pharma and Evec sign license agreement
Read More
NCI recruits patients for phase II trial of sipuleucel-T
Read More
Hybrigenics receives approval and funding for phase II inecalcitol trial in France
Read More
Promising results reported from phase II SAPHIRE trial
Read More
Inhibitex initiates phase II study of INX-08189
Read More
AMT and NIH sign exclusive license agreement for AAV-5-based gene therapy vectors
Read More
Noxxon Pharma begins first-in-human trial of NOX-H94
Read More
Evotec and Roche enter worldwide agreement for EVT-302
Read More
GeoVax Labs' HIV/AIDS vaccine development program receives NIAID grant boost
Read More
FDA expands indication of Baxter's Artiss
Read More
Randomized phase II trial to evaluate LY-2523355 in metastatic breast cancer
Read More
FDA issues warning regarding 5-alpha reductase inhibitors
Read More
Pharmasset releases SVR12 results from phase IIb study of PSI-7977
Read More